Top Clinical Trials companies in Germany by Net Cash Used For Investing Activities
Germany
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -2.01 M
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
| 2 |
USD -11.60 M
|
Dec. 31, 2023 | USD 2.11 | 3.12% |
|
Germany |
|
| 3 |
USD -19.53 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
|
| 4 |
USD -34.64 M
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
| 5 |
USD -39.80 M
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
| 6 |
USD -60.93 M
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
|
| 7 |
USD -7.68 B
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
Frequently Asked Questions
-
Which Clinical Trials company in Germany has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Germany with the highest Net Cash Used For Investing Activities is Mainz Biomed B.V. (NasdaqCM: MYNZ) at USD -2.01 M.
-
Which Clinical Trials company in Germany has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Germany with the lowest Net Cash Used For Investing Activities is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD -7.68 B.
-
What are the top 10 Clinical Trials companies in Germany by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Germany by Net Cash Used For Investing Activities are Mainz Biomed B.V., Vivoryon Therapeutics N.V., InflaRx N.V., Immatics N.V., Affimed N.V., CureVac N.V. and BioNTech SE.
-
What are the bottom 10 Clinical Trials companies in Germany by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Germany by Net Cash Used For Investing Activities are BioNTech SE, CureVac N.V., Affimed N.V., Immatics N.V., InflaRx N.V., Vivoryon Therapeutics N.V. and Mainz Biomed B.V..